Alveolar soft-part sarcoma (ASPS) is an uncommon, aggressive soft-tissue neoplasm, occurring in less than 1% of sarcomas. It is typically found in the head and neck tissues in children or in the deep soft tissues of the lower extremities in young adults. This tumor arises primarily within the skeletal muscles or musculofascial planes. Primary involvement of bone is extremely rare. ASPS has poor prognosis with a propensity for recurrence as well as distant metastasis. In this report, we present a 25-year-old male with primary ASPS in the left scapular bone and discuss the histopathological and immunohistochemical features of this sarcoma.
Introduction
Alveolar soft part sarcoma (ASPS) is rare, distinctive soft tissue sarcoma composed of large, uniform, epithelioid cells and characterized by ASPSCR1-TFE3 fusion gene [1] . It accounts for less than 1% of all soft tissue malignancies, and generally occurs between 15 and 35 years of age with a notable female predominance [1] [2] . ASPS usually presents as a slowly growing, painless mass [1] .
Pediatric ASPS appears most commonly in the head and neck tissues, however, lower extremity involvement may be found in young adults [3] . Primary bone involvement is occasional, and characteristically involves the fibula, ileum and tibia [4] . Only 2 cases with primary involvement of the scapular bone have been reported previously in the literature [3] . This case highlights some of the histopathological pitfalls in the diagnosis of ASPS and the possible unusual site of presentation. Another regimen of chemotherapy was proposed. However, the patient refused to complete the treatment and died seven months after the latest course of chemotherapy.
Discussion
ASPS is a rare soft-tissue malignancy that was originally alluded to by Smetana and Scott as a malignant tumor of the non-chromaffin paraganglia in 1951 [5] , and then described under its present name of "alveolar soft-part sarcoma" by Christopherson et al. in 1952 [1] . It occurs, in less than 1% of sarcomas, usually in adolescents and young adults, with a female predominance [3] [6] . ASPS primarily arises from the deep soft tissue of the extremities, trunk, retroperitoneum, head and neck. In children, ASPS has an unusual tendency to involve the tongue and orbit [7] [8] . Other locations, such as the female genital tract [6] , mediastinum [9] , lung [10] , gastrointestinal tract, are rare [11] . Primary bone involvement is occasional [12] , and it characteristically involves the fibula, ileum and tibia [4] . Only 2 cases with primary involvement of the scapular bone have been previously reported in the literature [3] . Radiologic findings reported in these cases were similar to ours: ill-defined osteolytic lesions on plain radiographs and expansile bone tumor with large intra-and extraosseous soft tissue masses on CT [3] . Park and al. [13] The most characteristic finding in ASPS is the consistent demonstration of strong nuclear immunoreactivity for TFE3, reflecting the ASPSCR1-TFE3 fusion gene that had been identified by cytogenetic analysis [4] [14] . Recent studies have shown that the crystals are immunoreactive to a protein MCT1 (monocarboxylate transporter) and to CD 147 [15] . About 50% of ASPS tumors express Desmin, as our case showed. Staining for protein S100 can be positive. Generally, epithelial, melanocytic, neural, glial, and neuroendocrine markers are negative [14] [16] .
The differential diagnosis of ASPS [4] [17] involves a wide range of neoplasms that contain a similar alveolar nest-like pattern. This includes renal, adrenal and hepatocellular carcinomas, which have a similar eosinophilic cytoplasm, but are distinguished by cytokeratin markers.
Melanoma can be differentiated by PAS negativity and positivity for melanocyticmarkers. Unlike ASPS, extra adrenal paragangliomas show strong expression of neuroendocrine markers and S100 typically is positive in the sustentacular cells. Granular cell tumors are strongly positive for S100, and lack the characteristic vascularization of ASPS.
Due to the alveolar architecture and occasional staining for muscle markers, a diagnosis of alveolar rhabdomyosarcoma may be considered, however, the cytology of ASPS is larger and with more abundant cytoplasm than seen in alveolar rhabdomyosarcomas. While both are highly vascularized tumors, the differentiation of ASPS from hemangioendothelioma is not commonly a diagnostic dilemma. Renal cell carcinoma occasionally mimics ASPS, but often shows focal tubular pattern of growth and lacks the crystals.
It is reported that ASPS is an indolent disease with characteristic slow growth, but that is associated with a poor overall outcome and a 5-year survival rate of only 20% in unresectable metastatic patients [18] . Unlike the rare cases described in the literature where patients have undergone surgical treatment and been relatively improved after treatment [3] , our patient had rapidly fatal outcome.
Metastasis can occur early sometimes before primary lesion detection or later after tumor resection even without local recurrence [14] . The most common sites of metastases are, in decreasing order of frequency, lung, bone and brain [14] . Metastases to the lymph nodes are not frequent [14] . Prognostic factors are age at presentation, tumor size and the presence of metastasisat diagnosis [14] .
Tumor size correlates with metastatic disease at onset and is the major factor influencing survival [19] .
Surgical excision remains the mainstay of therapy, and adjuvant chemotherapy and radiotherapy have no definite role in its management [15] [19] . In the present case the tumor was found to be infiltrating adjacent muscles therefore judged inoperable. The patient received adjuvant chemotherapy and continues to be on follow up.
Conclusion
In conclusion, this case is presented to highlight the distinctive clinical, morphological and immunohistochemical features of this unusual tumor. ASPS should be taken into consideration in the differential diagnosis of bone-originating soft tissue masses. Characteristic features of the lesion contribute to differentiating this entity from other bone tumors, primitive or metastatic.
